Unity Biotechnology, Inc. Total Liabilities
Unity Biotechnology, Inc. had Total Liabilities of $30.55 million as of 2025-03-31, per its 10-Q filed 2025-04-22.
Financial Statements › Balance Sheet › Liabilities
us-gaap:Liabilities · last filed 2025-04-22
- 2025-03-31: Liabilities $30.55M.
- 2024-12-31: Liabilities $31.17M.
- 2024-09-30: Liabilities $32.99M.
- 2024-06-30: Liabilities $33.77M.
| Period end | Liabilities | Liabilities as first filed |
|---|---|---|
| 2025-03-31 | $30.55M 10-Q · filed 2025-04-22 | |
| 2024-12-31 | $31.17M 10-Q · filed 2025-04-22 | |
| 2024-09-30 | $32.99M 10-Q · filed 2024-11-04 | |
| 2024-06-30 | $33.77M 10-Q · filed 2024-08-06 | |
| 2024-03-31 | $34.88M 10-Q · filed 2024-05-14 | |
| 2023-12-31 | $37.29M 10-K · filed 2025-03-07 | |
| 2023-09-30 | $41.55M 10-K · filed 2024-04-15 | $33.06M 10-Q · filed 2023-11-13 |
| 2023-06-30 | $60.24M 10-K · filed 2024-04-15 | $51.60M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $60.90M 10-K · filed 2024-04-15 | $55.63M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $68.27M 10-K · filed 2024-04-15 | $57.50M 10-K · filed 2023-03-15 |
| 2022-09-30 | $75.19M 10-K · filed 2024-04-15 | $57.83M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $57.66M 10-Q · filed 2022-08-12 | |
| 2022-03-31 | $61.78M 10-Q · filed 2022-05-10 | |
| 2021-12-31 | $65.14M 10-K · filed 2023-03-15 | |
| 2021-09-30 | $67.95M 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $70.35M 10-Q · filed 2021-08-10 | |
| 2021-03-31 | $68.23M 10-Q · filed 2021-05-11 | |
| 2020-12-31 | $73.44M 10-K · filed 2022-03-15 | |
| 2020-09-30 | $76.87M 10-Q · filed 2020-11-04 | |
| 2020-06-30 | $52.44M 10-Q · filed 2020-07-31 | |
| 2020-03-31 | $52.46M 10-Q · filed 2020-05-07 | |
| 2019-12-31 | $30.51M 10-K · filed 2021-03-23 | |
| 2019-09-30 | $26.96M 10-Q · filed 2019-11-06 | |
| 2019-06-30 | $27.16M 10-Q · filed 2019-08-07 | |
| 2019-03-31 | $14.19M 10-Q · filed 2019-05-08 | |
| 2018-12-31 | $20.68M 10-K · filed 2020-03-11 | |
| 2018-09-30 | $15.21M 10-Q · filed 2018-11-07 | |
| 2018-06-30 | $13.39M 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $13.83M 10-Q · filed 2018-06-07 | |
| 2017-12-31 | $11.18M 10-K · filed 2019-03-06 |